Suchergebnisse - "Brucoli, Federico"

PubPharm (30)

1

CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues

enthalten in: Molecules (Basel, Switzerland) | 2024

von Ruparelia, K. | Zeka, K. | Beresford, K. | +5

2

Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex

enthalten in: Bioorganic chemistry | 2023

von Murnane, R. | Zloh, M. | Tanna, S. | +4

3

Aminobenzofuran-containing analogues of proximicins exhibit higher antiproliferative activity against human UG-87 glioblastoma cells compared to temozolomide

enthalten in: RSC advances | 2023

von Shokrzadeh Madieh, N. | Tanna, S. | Alqurayn, N. | +3

4

C2-linked alkynyl poly-ethylene glycol(PEG) adenosine conjugates as water-soluble adenosine receptor agonists

enthalten in: Chemical biology & drug design | 2023

von Ferguson, L. | Madieh, N. | Vaideanu, A. | +6

5

C2‐linked alkynyl poly‐ethylene glycol( PEG) adenosine conjugates as water‐soluble adenosine receptor agonists

enthalten in: Chemical Biology & Drug Design | 2023

von Ferguson, L. | Madieh, N. | Vaideanu, A. | +6

6

Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition

enthalten in: Journal of medicinal chemistry | 2022

von Shyam, M. | Verma, H. | Bhattacharje, G. | +19

7

Rifamycins : do not throw the baby out with the bathwater. Is rifampicin still an effective anti-tuberculosis drug?

enthalten in: Future medicinal chemistry | 2021

von Brucoli, F. | D McHugh, T.

8

Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoBS522L strain and display a different binding mode at the RNAP β-subunit site compared to rifampicin

enthalten in: European journal of medicinal chemistry | 2021

von Zloh, M. | Gupta, M. | Parish, T. | +1

9

The Mycobactin Biosynthesis Pathway : A Prospective Therapeutic Target in the Battle against Tuberculosis

enthalten in: Journal of medicinal chemistry | 2021

von Shyam, M. | Shilkar, D. | Verma, H. | +5

10

Rifamycins: do not throw the baby out with the bathwater. Is rifampicin still an effective anti-tuberculosis drug?

enthalten in: Future medicinal chemistry | 2021

von Brucoli, F. | D McHugh, T.